Stay updated with breaking news from Philipm Brown. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
- ADORING 1 and ADORING 2 met their primary efficacy endpoints and all secondary endpoints - - ADORING 1 and ADORING 2 data were included in the sNDA filing for VTAMA cream, 1% in atopic dermatitis
Tapinarof cream was found to be an effective treatment for plaque psoriasis of the head and neck region in adults, according to phase 4 trial data.
Treatment with tapinarof cream led to significant symptom improvement in adult and pediatric patients with atopic dermatitis.
Roivant Sciences Limited saw its shares rise after its subsidiary Dermavant Sciences reported positive topline results from ADORING 2, one of two Phase 3...
Tapinarof cream was found to be beneficial for atopic dermatitis patients as young as 2 years old, according to findings from the phase 3 ADORING 2 trial.